Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept

BACKGROUND: Patients with rheumatoid arthritis (RA), including those treated with biologics, are at increased risk of some vaccine-preventable infections. We evaluated the antibody response to standard 23-valent pneumococcal polysaccharide vaccine (PPSV23) and the 2011–2012 trivalent seasonal influe...

Descripción completa

Detalles Bibliográficos
Autores principales: Alten, Rieke, Bingham, Clifton O., Cohen, Stanley B., Curtis, Jeffrey R., Kelly, Sheila, Wong, Dennis, Genovese, Mark C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880815/
https://www.ncbi.nlm.nih.gov/pubmed/27229685
http://dx.doi.org/10.1186/s12891-016-1082-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880815/
https://www.ncbi.nlm.nih.gov/pubmed/27229685
http://dx.doi.org/10.1186/s12891-016-1082-z

Ejemplares similares